| NCT Number | NCT07226635 |
| Lead Sponsor | Sparrow Pharmaceuticals |
| Conditions | Healthy Participants |
| Enrollment | 16 participants |
| Start Date | 2025-10-03 |
| Primary Completion | 2025-12-16 (estimated) |
| Study Completion | 2025-12-16 (estimated) |
| Updated on ClinicalTrials.gov | 2026-07-08 |